PRA’s Arjen Akkerman and Suzanne Jansen discuss how Chemistry, Manufacturing and Controls (CMC) services integrated with a clinical setting can help to shorten timelines, whereby clinical safety data may be obtained in an early drug development stage. The authors also compare the differences between the US and EU regarding early clinical drug development.
PRA Health Sciences Laboratory Publication List
A list of 2019-2020 publications from the labs team.
Bioanalysis, Biomarker and Flow Cytometry Assay List
Bioanalysis, Biomarker and Flow Cytometry Assay List. PRA Laboratories—Solutions for Drug Development. Behind every sample waiting to be analyzed,…
Bioanalysis and Beyond: PRA’s Contributions to Patient Care and Advocacy in the Lab
The experts in PRA’s Bioanalytical Laboratories use a patient-centric approach to ensure that their work reflects what patients need and bring that…